138 related articles for article (PubMed ID: 16338425)
1. Toxin conjugate therapy of cancer.
Wong L; Suh DY; Frankel AE
Semin Oncol; 2005 Dec; 32(6):591-5. PubMed ID: 16338425
[TBL] [Abstract][Full Text] [Related]
2. Recombinant toxins for the treatment of cancer.
Kreitman RJ
Curr Opin Mol Ther; 2003 Feb; 5(1):44-51. PubMed ID: 12669470
[TBL] [Abstract][Full Text] [Related]
3. Targeted therapy of cancer using diphtheria toxin-derived immunotoxins.
Potala S; Sahoo SK; Verma RS
Drug Discov Today; 2008 Sep; 13(17-18):807-15. PubMed ID: 18678276
[TBL] [Abstract][Full Text] [Related]
4. Immunotoxins and cancer therapy.
Li Z; Yu T; Zhao P; Ma J
Cell Mol Immunol; 2005 Apr; 2(2):106-12. PubMed ID: 16191416
[TBL] [Abstract][Full Text] [Related]
5. Diphtheria toxin conjugate therapy of cancer.
Frankel AE; Powell BL; Lilly MB
Cancer Chemother Biol Response Modif; 2002; 20():301-13. PubMed ID: 12703211
[TBL] [Abstract][Full Text] [Related]
6. Humanized immunotoxins: a new generation of immunotoxins for targeted cancer therapy.
Mathew M; Verma RS
Cancer Sci; 2009 Aug; 100(8):1359-65. PubMed ID: 19459847
[TBL] [Abstract][Full Text] [Related]
7. Protein toxins: intracellular trafficking for targeted therapy.
Johannes L; Decaudin D
Gene Ther; 2005 Sep; 12(18):1360-8. PubMed ID: 15902276
[TBL] [Abstract][Full Text] [Related]
8. Advances in anticancer immunotoxin therapy.
Alewine C; Hassan R; Pastan I
Oncologist; 2015 Feb; 20(2):176-85. PubMed ID: 25561510
[TBL] [Abstract][Full Text] [Related]
9. Current status of antibody-toxin conjugates for tumor therapy.
Ramakrishnan S
Targeted Diagn Ther; 1990; 3():189-213. PubMed ID: 2131010
[No Abstract] [Full Text] [Related]
10. Patents on immunotoxins and chimeric toxins for the treatment of cancer.
Bachran C; Sutherland M; Bachran D; Fuchs H
Recent Pat Drug Deliv Formul; 2007; 1(2):105-15. PubMed ID: 19075878
[TBL] [Abstract][Full Text] [Related]
11. Immunotoxins: the role of the toxin.
Antignani A; Fitzgerald D
Toxins (Basel); 2013 Aug; 5(8):1486-502. PubMed ID: 23965432
[TBL] [Abstract][Full Text] [Related]
12. Immunotoxin therapy of cancer.
Pastan I; Hassan R; Fitzgerald DJ; Kreitman RJ
Nat Rev Cancer; 2006 Jul; 6(7):559-65. PubMed ID: 16794638
[TBL] [Abstract][Full Text] [Related]
13. Recombinant immunotoxins in targeted cancer cell therapy.
Reiter Y
Adv Cancer Res; 2001; 81():93-124. PubMed ID: 11430597
[TBL] [Abstract][Full Text] [Related]
14. Bacterial Toxins for Cancer Therapy.
Zahaf NI; Schmidt G
Toxins (Basel); 2017 Jul; 9(8):. PubMed ID: 28788054
[TBL] [Abstract][Full Text] [Related]
15. [Recombinant immunotoxin for cancer therapy: current status and prospective].
Nagata S
Tanpakushitsu Kakusan Koso; 2001 Mar; 46(4 Suppl):540-6. PubMed ID: 11268658
[No Abstract] [Full Text] [Related]
16. Immunotoxin: A new tool for cancer therapy.
Allahyari H; Heidari S; Ghamgosha M; Saffarian P; Amani J
Tumour Biol; 2017 Feb; 39(2):1010428317692226. PubMed ID: 28218037
[TBL] [Abstract][Full Text] [Related]
17. Local treatment of brain tumors with targeted chimera cytotoxic proteins.
Debinski W
Cancer Invest; 2002; 20(5-6):801-9. PubMed ID: 12197239
[TBL] [Abstract][Full Text] [Related]
18. Immunotoxin therapy of hematological malignancies.
Pasqualucci L; Flenghi L; Terenzi A; Bolognesi A; Stirpe F; Bigerna B; Falini B
Haematologica; 1995; 80(6):546-56. PubMed ID: 8647523
[No Abstract] [Full Text] [Related]
19. Treatment of solid tumors with immunotoxins.
Messmer D; Kipps TJ
Breast Cancer Res; 2005; 7(5):184-6. PubMed ID: 16168135
[TBL] [Abstract][Full Text] [Related]
20. Targeted cancer therapy: conferring specificity to cytotoxic drugs.
Chari RV
Acc Chem Res; 2008 Jan; 41(1):98-107. PubMed ID: 17705444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
